arrow
D

Dana Lucia Stănculeanu

institute of oncology prof. dr. al trestioreanu
H指数:13
被引数:718

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Cardiotoxicity Associated with Antineoplastic Therapy: A Multidisciplinary Approach to Personalized Monitoring Using Radionuclide Imaging and Molecular Biomarkers

抗肿瘤治疗相关心脏毒性:利用放射性核素成像和分子生物标志物进行个性化监测的多学科方法

2026-05-010
PRE
Integrative sWGS: A New Paradigm for HRD Detection in Ovarian Cancer

整合单细胞全基因组测序:卵巢癌中HRD检测的新范式

2025-12-120
OAAI
miRNA and Its Implications in the Treatment Resistance in Breast Cancer—Narrative Review of What Do We Know So Far

miRNA及其在乳腺癌治疗耐药性中的意义——关于我们目前所知内容的叙事性综述

2025-11-190
OAAI
Enhancing Prognosis in Advanced Ovarian Cancer: Primary Cytoreductive Surgery and Adjuvant Chemotherapy or Neoadjuvant Chemotherapy and Interval Cytoreduction-A Single-Center Retrospective Observational Study

提高晚期卵巢癌预后:初次肿瘤细胞减灭术与辅助化疗或新辅助化疗与间隔肿瘤细胞减灭术——一项单中心回顾性观察研究

CANCERS
IF4.4
2025-04-140
OA
Treatment Strategies In Advanced Ovarian Cancer: Primary Cytoreductive Surgery And Adjuvant Chemotherapy Versus Neoadjuvant Chemotherapy And Interval Cytoreduction - A Single-Center Retrospective Observational Study From Romania

高级卵巢癌的治疗策略:初次肿瘤细胞减灭术和辅助化疗与术前新辅助化疗和间隔肿瘤细胞减灭术——一项来自罗马尼亚的单中心回顾性观察性研究

2025-02-010
PRE
Patients with endometrial cancer: Expectations and understanding of genetic counseling and hereditary carcinomas - First results of an international NOGGO/GCIG/ENGOT survey (EXPRESSION XI/IMPROVE)
2023-10-010
OA
Analysis of hereditary cancer syndromes by using a panel of genes: novel and multiple pathogenic mutations
2019-06-03105
OAAI